Insider · CIK 0001484322
Jeffrey W Burris
Files at INDV (Indivior Pharmaceuticals, Inc.). First filing -, latest -.
Jeffrey W Burris files SEC Form 4 as officer at INDV (Indivior Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jeffrey W Burris has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | INDV Indivior Pharmaceuticals, Inc. | MOption exercise Common Stock | +79,893 | - | - | 107,550 | Mar 5, 2026 |
| Mar 3, 2026 | INDV Indivior Pharmaceuticals, Inc. | FTax withholding Common Stock | -36,032 | $31.98 | $1.2M | 71,518 | Mar 5, 2026 |
| Mar 3, 2026 | INDV Indivior Pharmaceuticals, Inc. | MOption exercise Performance Stock Unitsderivative | -104,300 | - | - | 0 | Mar 5, 2026 |
| Feb 10, 2026 | INDV Indivior Pharmaceuticals, Inc. | AGrant or award Common Stock | +26,897 | $0.00 | $0 | 27,657 | Feb 12, 2026 |
| Feb 9, 2026 | INDV Indivior Pharmaceuticals, Inc. | AGrant or award Performance Stock Unitsderivative | +104,300 | $0.00 | $0 | 104,300 | Feb 12, 2026 |
Questions about Jeffrey W Burris
Answered from the filings on this page, as of the latest one.
Is Jeffrey W Burris buying or selling?
Jeffrey W Burris has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jeffrey W Burris's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jeffrey W Burris has 0.
Where does Jeffrey W Burris file Form 4?
Jeffrey W Burris has filed Form 4 at INDV (Indivior Pharmaceuticals, Inc.) as Chief Legal Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.